Melissa Anxiety Randomized Trial: What the Evidence Says

Quick Answer

Melissa Anxiety Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 preclinical study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• The situation is even more complex in patients with type 2 diabetes (T2D), which is an independent risk factor for all forms of CVD. [Chen Ruofei (2026); evidence level 4]
• Individuals with T2D are up to 3 times more likely to experience a cardiovascular event compared to those without diabetes, associated with a significant reduction in life expectancy of up to 5 years. [Chen Ruofei (2026); evidence level 4]
• Historical use of medicinal plants was a result of cumulative trial and error experience and the transmission of traditional knowledge between generations, which later inspired systematic efforts to turn empirical claims into evidence-based arguments. [Cîmpeanu Ioan-Alexandru (2026); evidence level 4]
• Also, standardization and phytochemical reporting is the preferred method for interpreting the evidence base across Lamiaceae, as its composition is influenced by genetics, geography, cultivation, and post-harvest handling. [Cîmpeanu Ioan-Alexandru (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For melissa anxiety randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Chen Ruofei (2026). Evaluation of Polygenic Scores and CT Imaging in Risk Factor Modification in Patients With Diabetes: Rationale and Design of the VOLTAIRE Study. DOI: 10.1002/clc.70363. PMCID: PMC13240284. PMID: 42223325. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13240284/
• Cîmpeanu Ioan-Alexandru (2026). Melissa officinalis L. (Lemon Balm): An Integrative Review of Phytochemistry and Evidence from Preclinical Research to Clinical Studies. DOI: 10.3390/plants15040650. PMCID: PMC12944213. PMID: 41754356. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12944213/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.